UBS Group’s Aimei Health Technology Co Unit AFJKU Stock Holding History

UBS Group’s Portfolio AFJKU Stock Details AFJKU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7	Closed	-$78	–	11540
2025 Q3	$78	Buy	+7	New	+$78	﹤0.01%	9961
2024 Q3	–	Sell	-66	Closed	-$696	–	10547
2024 Q2	$696	Buy	66 +25	+61%	+$263	﹤0.01%	8818
2024 Q1	$446	Sell	41 -247	-86%	-$2.56K	﹤0.01%	8558
2023 Q4	$2.94K	Buy	+288	New	+$2.93K	﹤0.01%	8036

UBS Group's AFJKU Position: Q4 2025 in Review

UBS Group sold out of Aimei Health Technology Co Unit (AFJKU) in Q4 2025, closing a stake of 7 shares — an estimated $78 sold.

UBS Group first reported a position in AFJKU in Q4 2023 and held it in 4 quarters. The position peaked at $2.94K in Q4 2023. 0 funds tracked by Wall St. Rank hold AFJKU as of Q4 2025.

UBS Group reported no remaining Aimei Health Technology Co Unit position as of Q4 2025 after selling out during the quarter.
UBS Group sold 7 Aimei Health Technology Co Unit shares in Q4 2025, an estimated $78.
UBS Group first reported a position in Aimei Health Technology Co Unit in Q4 2023 and held it in 4 quarters.
UBS Group's Aimei Health Technology Co Unit position peaked at $2.94K in Q4 2023.
0 funds tracked by Wall St. Rank held Aimei Health Technology Co Unit as of Q4 2025.

Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.